Contribution: Industrial Research Assistance Program – Contributions to Firms
Augurex Life Sciences Corp.
$49,999.00
Identification of a Lead Compound for the Treatment of Rheumatoid Arthritis (RA)
FY 2016-17 · 2016-09-01
Summary
The main objective of this project is to identify a lead biological candidate for the treatment of Rheumatoid Arthritis (RA).
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
829919521
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Additional Information
The end date of this agreement has been modified by 213 days.
Additional Information (French)
La date de fin du présent accord a été changé (213 jours)
Agreement End Date
2019-09-30
Agreement Number
872369
Agreement Start Date
2016-09-01
Agreement Title
Identification of a Lead Compound for the Treatment of Rheumatoid Arthritis (RA)
Agreement Title (French)
Identification d’un composé de plomb pour le traitement de la polyarthrite rhumatoïde (PR)
Agreement Type
Contribution
Agreement Value
$49,999.00
Amendment Date
2018-05-22
Amendment Number
3
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The main objective of this project is to identify a lead biological candidate for the treatment of Rheumatoid Arthritis (RA).
Description (French)
L’objectif principal de ce projet consiste à trouver un candidat de plomb biologique pour le traitement de la polyarthrite rhumatoïde (PR).
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver East
Federal Riding (French)
Vancouver-Est
Federal Riding Number
59035
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
829919521
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
Augurex Life Sciences Corp.
Recipient Operating Name
Augurex
Recipient Postal Code
V5T 4T5
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2018-2019-Q1-872369
